In the BioHarmony Drug Report Database
Tadalafil
Adcirca, Cialis, Tadalafil Lilly (tadalafil) is a small molecule pharmaceutical. Tadalafil was first approved as Adcirca on 2002-11-12. It is used to treat pulmonary hypertension and vasculogenic impotence in the USA. It has been approved in Europe to treat erectile dysfunction and pulmonary hypertension. The pharmaceutical is active against cGMP-specific 3′,5′-cyclic phosphodiesterase. In addition, it is known to target dual 3′,5′-cyclic-AMP and -GMP phosphodiesterase 11A.
Trade Name
|
Adcirca, Cialis, Tadalafil Lilly, Tadalafil Lilly |
|---|---|
Common Name
|
tadalafil |
ChEMBL ID
|
CHEMBL779 |
Indication
|
erectile dysfunction, pulmonary hypertension, vasculogenic impotence |
Drug Class
|
Pde5 inhibitors |
Image (chem structure or protein)